Average Co-Inventor Count = 7.20
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (20 from 124 patents)
2. Valo Early Discovery, Inc. (5 from 15 patents)
3. Valo Health, Inc. (3 from 29 patents)
4. Acurx Pharmaceuticals, LLC (3 from 4 patents)
31 patents:
1. 12043623 - Purinones as ubiquitin-specific protease 1 inhibitors
2. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
3. 11795171 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
4. 11739071 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
5. 11161848 - Purinones as ubiquitin-specific protease 1 inhibitors
6. 11001592 - DNA polymerase IIIC inhibitors and use thereof
7. 10981915 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
8. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
9. 10927130 - Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
10. 10906916 - Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
11. 10836772 - DNA polymerase IIIC inhibitors and use thereof
12. 10836741 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
13. 10723741 - DNA polymerase IIIC inhibitors and use thereof
14. 10519127 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
15. 10519128 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors